Data Sheet 2_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.pdf

Background<p>Detecting multiple sclerosis (MS) relapses remains challenging due to symptom variability and confounding factors, such as flare-ups and infections. Methylprednisolone (MP) is used for severe relapses, decreasing the number of contrast-enhancing lesions on MRI. The influx constant...

Full description

Saved in:

Bibliographic Details
Main Author:	Stig P. Cramer (20908724) (author)
Other Authors:	Nizar Hamrouni (20908727) (author), Helle J. Simonsen (20908730) (author), Mark B. Vestergaard (5349389) (author), Aravinthan Varatharaj (9748350) (author), Ian Galea (3151215) (author), Ulrich Lindberg (4050718) (author), Jette Lautrup Frederiksen (6001223) (author), Henrik B. W. Larsson (20908733) (author)
Published:	2025
Subjects:	Neuroscience MRI DCE MRI perfusion MRI blood–brain barrier multiple sclerosis: multiple sclerosis relapses methylprednisolone
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Data Sheet 2_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.pdf

Similar Items